4
Changes in Ownership
Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-18-016652
Options or other derivatives
- Director acquired 9,100 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| McBride John S. Director | 2018-06-13 | Grant or award · Stock Option (Right to Buy) | +9,100 | 9,100 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…